Optimization of the SARS-CoV-2 ARTIC Network V4 Primers and Whole Genome Sequencing Protocol

被引:49
作者
Lambisia, Arnold W. [1 ]
Mohammed, Khadija S. [1 ]
Makori, Timothy O. [1 ]
Ndwiga, Leonard [1 ]
Mburu, Maureen W. [1 ]
Morobe, John M. [1 ]
Moraa, Edidah O. [1 ]
Musyoki, Jennifer [1 ]
Murunga, Nickson [1 ]
Mwangi, Jane N. [1 ]
Nokes, D. James [1 ,2 ]
Agoti, Charles N. [1 ,3 ]
Ochola-Oyier, Lynette Isabella [1 ,4 ]
Githinji, George [1 ,5 ]
机构
[1] Kenya Med Res Inst KEMR, Wellcome Trust Res Programme KWTRP, Kilifi, Kenya
[2] Univ Warwick, Dept Biol Sci, Coventry, W Midlands, England
[3] Pwani Univ, Nuffield Dept Med, Kilifi, Kenya
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
[5] Pwani Univ, Dept Biochem & Biotechnol, Kilifi, Kenya
基金
美国国家卫生研究院; 英国惠康基金;
关键词
ARTIC V4; SARS-CoV-2; whole genome sequencing; amplicon drop-offs; protocol;
D O I
10.3389/fmed.2022.836728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The ARTIC Network's primer set and amplicon-based protocol is one of the most widely used SARS-CoV-2 sequencing protocol. An update to the V3 primer set was released on 18th June 2021 to address amplicon drop-off observed among the Delta variant of concern. Here, we report on an in-house optimization of a modified version of the ARTIC Network V4 protocol that improves SARS-CoV-2 genome recovery in instances where the original V4 pooling strategy was characterized by amplicon drop-offs.Methods: We utilized a matched set of 43 clinical samples and serially diluted positive controls that were amplified by ARTIC V3, V4 and optimized V4 primers and sequenced using GridION from the Oxford Nanopore Technologies'.Results: We observed a 0.5% to 46% increase in genome recovery in 67% of the samples when using the original V4 pooling strategy compared to the V3 primers. Amplicon drop-offs at primer positions 23 and 90 were observed for all variants and positive controls. When using the optimized protocol, we observed a 60% improvement in genome recovery across all samples and an increase in the average depth in amplicon 23 and 90. Consequently, & GE;95% of the genome was recovered in 72% (n = 31) of the samples. However, only 60-70% of the genomes could be recovered in samples that had < 28% genome coverage with the ARTIC V3 primers. There was no statistically significant (p > 0.05) correlation between Ct value and genome recovery.Conclusion: Utilizing the ARTIC V4 primers, while increasing the primer concentrations for amplicons with drop-offs or low average read-depth, greatly improves genome recovery of Alpha, Beta, Delta, Eta and non-VOC/non-VOI SARS-CoV-2 variants.
引用
收藏
页数:8
相关论文
共 30 条
[21]  
Quick J., 2020, NCOV 2019 SEQ PROT V
[22]   Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples [J].
Quick, Joshua ;
Grubaugh, Nathan D. ;
Pullan, Steven T. ;
Claro, Ingra M. ;
Smith, Andrew D. ;
Gangavarapu, Karthik ;
Oliveira, Glenn ;
Robles-Sikisaka, Refugio ;
Rogers, Thomas F. ;
Beutler, Nathan A. ;
Burton, Dennis R. ;
Lewis-Ximenez, Lia Laura ;
de Jesus, Jaqueline Goes ;
Giovanetti, Marta ;
Hill, Sarah C. ;
Black, Allison ;
Bedford, Trevor ;
Carroll, Miles W. ;
Nunes, Marcio ;
Alcantara, Luiz Carlos, Jr. ;
Sabino, Ester C. ;
Baylis, Sally A. ;
Faria, Nuno R. ;
Loose, Matthew ;
Simpson, Jared T. ;
Pybus, Oliver G. ;
Andersen, Kristian G. ;
Loman, Nicholas J. .
NATURE PROTOCOLS, 2017, 12 (06) :1261-1276
[23]  
Sanderson T., SYSTEMATIC ERRORS AS
[24]  
Scalene, 2021, SARS COV 2 V4 1 UPD
[25]   GISAID: Global initiative on sharing all influenza data - from vision to reality [J].
Shu, Yuelong ;
McCauley, John .
EUROSURVEILLANCE, 2017, 22 (13) :2-4
[26]  
Tyson JR, 2020, bioRxiv, DOI [10.1101/2020.09.04.283077, 10.1101/2020.09.04.283077, DOI 10.1101/2020.09.04.283077]
[27]  
WHO, GEN SEQ SARS COV 2, P94
[28]   A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa [J].
Wilkinson, Eduan ;
Giovanetti, Marta ;
Tegally, Houriiyah ;
San, James E. ;
Lessells, Richard ;
Cuadros, Diego ;
Martin, Darren P. ;
Rasmussen, David A. ;
Zekri, Abdel-Rahman N. ;
Sangare, Abdoul K. ;
Ouedraogo, Abdoul-Salam ;
Sesay, Abdul K. ;
Priscilla, Abechi ;
Kemi, Adedotun-Sulaiman ;
Olubusuyi, Adewunmi M. ;
Oluwapelumi, Adeyemi O. O. ;
Hammami, Adnene ;
Amuri, Adrienne A. ;
Sayed, Ahmad ;
Ouma, Ahmed E. O. ;
Elargoubi, Aida ;
Ajayi, Nnennaya A. ;
Victoria, Ajogbasile F. ;
Kazeem, Akano ;
George, Akpede ;
Trotter, Alexander J. ;
Yahaya, Ali A. ;
Keita, Alpha K. ;
Diallo, Amadou ;
Kone, Amadou ;
Souissi, Amal ;
Chtourou, Amel ;
Gutierrez, Ana, V ;
Page, Andrew J. ;
Vinze, Anika ;
Iranzadeh, Arash ;
Lambisia, Arnold ;
Ismail, Arshad ;
Rosemary, Audu ;
Sylverken, Augustina ;
Femi, Ayoade ;
Ibrahimi, Azeddine ;
Marycelin, Baba ;
Oderinde, Bamidele S. ;
Bolajoko, Bankole ;
Dhaala, Beatrice ;
Herring, Belinda L. ;
Njanpop-Lafourcade, Berthe-Marie ;
Kleinhans, Bronwyn ;
McInnis, Bronwyn .
SCIENCE, 2021, 374 (6566) :423-+
[29]   A new coronavirus associated with human respiratory disease in China [J].
Wu, Fan ;
Zhao, Su ;
Yu, Bin ;
Chen, Yan-Mei ;
Wang, Wen ;
Song, Zhi-Gang ;
Hu, Yi ;
Tao, Zhao-Wu ;
Tian, Jun-Hua ;
Pei, Yuan-Yuan ;
Yuan, Ming-Li ;
Zhang, Yu-Ling ;
Dai, Fa-Hui ;
Liu, Yi ;
Wang, Qi-Min ;
Zheng, Jiao-Jiao ;
Xu, Lin ;
Holmes, Edward C. ;
Zhang, Yong-Zhen .
NATURE, 2020, 579 (7798) :265-+
[30]   Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy [J].
Zhang, Qianqian ;
Xiang, Rong ;
Huo, Shanshan ;
Zhou, Yunjiao ;
Jiang, Shibo ;
Wang, Qiao ;
Yu, Fei .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)